3-Chloro-2-iodopyridine

We are 3-Chloro-2-iodopyridine CAS:77332-89-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Chloro-2-iodopyridine
CAS.NO:77332-89-9
Synonyms:3-Chloro-2-iodopyridine
2-iodo-3-chloropyridine
Pyridine,3-chloro-2-iodo
2-iodo-3-pyridyl chloride
 
Physical and Chemical Properties:
Density 2.1±0.1 g/cm3
Boiling Point 245.0±20.0 °C at 760 mmHg
Molecular Formula C5H3ClIN
Molecular Weight 239.441
Flash Point 102.0±21.8 °C
 
Specification:
Appearance:Gray-white crystal
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

3-Chloro-2-iodopyridine


Related News: Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity.2-chloro-3-[4-(4-chlorophenyl)cyclohexyl]naphthalene-1,4-dione Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.2-Bromo-4-fluorobenzoic acid With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.3-hidroxi-2'-metil-2-naftanilida CAS:135-61-5 Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.

Related Products
Product Name
4-Chloro-2-fluorotoluene View Details
2-Hydroxy-3-methyl-2-cyclopentenone View Details
3-Ethoxy-4-methoxybenzaldehyde View Details
2-(4-hydroxyphenyl)-1-benzothiophen-6-ol manufacturer 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid manufacturer D-Proline Methyl Ester manufacturer 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid manufacturer (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid manufacturer